Omaha World Herald Article RatingAccess to abortion pill in limbo
- Bias Rating
14% Somewhat Conservative
- Reliability
30% ReliableFair
- Policy Leaning
10% Center
- Politician Portrayal
22% Negative
Extremely
Liberal
Very
Liberal
Moderately
Liberal
Somewhat Liberal
Center
Somewhat Conservative
Moderately
Conservative
Very
Conservative
Extremely
Conservative
-100%
Liberal
100%
Conservative
Continue For Free
Create your free account to see the in-depth bias analytics and more.
Continue
Continue
By creating an account, you agree to our Terms and Privacy Policy, and subscribe to email updates. Already a member: Log inBias Score Analysis
The A.I. bias rating includes policy and politician portrayal leanings based on the author’s tone found in the article using machine learning. Bias scores are on a scale of -100% to 100% with higher negative scores being more liberal and higher positive scores being more conservative, and 0% being neutral.
Sentiments
N/A
- Conservative
| Sentence | Sentiment | Bias |
|---|---|---|
| "PAUL J. WEBER, MATTHEW PERRONE and LINDSAY WHITEHURST Associated Press PAUL J. WEBER, MATTHEW PERRONE and LINDSAY WHITEHURST Associated PressAUSTIN, Texas -- Access to the most commonly used method of abortion in the U.S. plunged into uncertainty Friday after conflicting court rulings over the legality of the abortion medication mifepristone that has been widely available for more than 20 years." | Negative | -2% Liberal |
| "The extraordinary timing of the competing orders revealed the high stakes surrounding the drug almost a year after the U.S. Supreme Court overturned Roe v. Wade and curtailed access to abortion across the country." | Negative | -8% Liberal |
| "U.S. District Judge Matthew Kacsmaryk, a Trump appointee, ordered a hold on federal approval of mifepristone in a decision that overruled decades of scientific approval." | Positive | 4% Conservative |
| "That decision came at nearly same time that U.S. District Judge Thomas O. Rice, an Obama appointee, essentially ordered the opposite and directed U.S. authorities not to make changes that would restrict access to the drug in at least 17 states where Democrats sued in an effort to protect availability." | Negative | -24% Liberal |
Bias Meter
Extremely
Liberal
Very
Liberal
Moderately
Liberal
Somewhat Liberal
Center
Somewhat Conservative
Moderately
Conservative
Very
Conservative
Extremely
Conservative
-100%
Liberal
100%
Conservative
Contributing sentiments towards policy:
49% : PAUL J. WEBER, MATTHEW PERRONE and LINDSAY WHITEHURST Associated Press PAUL J. WEBER, MATTHEW PERRONE and LINDSAY WHITEHURST Associated PressAUSTIN, Texas -- Access to the most commonly used method of abortion in the U.S. plunged into uncertainty Friday after conflicting court rulings over the legality of the abortion medication mifepristone that has been widely available for more than 20 years.46% : The extraordinary timing of the competing orders revealed the high stakes surrounding the drug almost a year after the U.S. Supreme Court overturned Roe v. Wade and curtailed access to abortion across the country.
*Our bias meter rating uses data science including sentiment analysis, machine learning and our proprietary algorithm for determining biases in news articles. Bias scores are on a scale of -100% to 100% with higher negative scores being more liberal and higher positive scores being more conservative, and 0% being neutral. The rating is an independent analysis and is not affiliated nor sponsored by the news source or any other organization.